Clinical Trials Logo

Clinical Trial Summary

The Stage 1 of this phase 2 study is an open-label single ascending dose (SAD) study. The primary objectives are to evaluate the safety and tolerability of injection lipolysis with CBL-514. It will be followed by a parallel-arm multiple-dose design in Stage 2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04575467
Study type Interventional
Source Caliway Biopharmaceuticals Co., Ltd.
Contact
Status Completed
Phase Phase 2
Start date December 9, 2020
Completion date December 8, 2021

See also
  Status Clinical Trial Phase
Completed NCT04699669 - A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers Phase 1
Completed NCT02512822 - Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring N/A
Recruiting NCT06005441 - A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. Phase 2
Active, not recruiting NCT05736107 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat Phase 2
Not yet recruiting NCT03160976 - Cryolipolysis on Localized Adiposity N/A
Completed NCT03871556 - Diagnostic Ultrasound for Measuring Fat of the Body N/A
Completed NCT02098811 - Evaluation of the Safety and Precursors of Efficacy N/A
Active, not recruiting NCT04553627 - Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis N/A
Completed NCT02539043 - Effects of Ultrasound Cavitation Focused on Located Adiposity N/A
Completed NCT01842802 - Clinical Investigation of Non Invasive Fat Reduction N/A
Completed NCT04698642 - A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat Phase 2
Completed NCT02052622 - Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Phase 3
Completed NCT04897412 - A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) Phase 2
Completed NCT03682471 - Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
Completed NCT05234736 - A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers Phase 2